Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus

Clinical trial NCT00739635 · COMPLETED

Trial details

NCT number: NCT00739635
Sponsor: Merz Pharmaceuticals GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Subjective Tinnitus

Start date: 2008-09-01
Primary completion: 2010-02-01
Enrollment: 411

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.